Characterization of preclinical radio ADME properties of ARV-471 for predicting human PK using PBPK modeling

Proteolysis-targeting chimeras (PROTACs) represent a promising class of drugs that can target disease-causing proteins more effectively than traditional small molecule inhibitors can, potentially revolutionizing drug discovery and treatment strategies. However, the links between in vitro and in vivo...

Полное описание

Библиографические подробности

Главные авторы:	Yifei He, Chenggu Zhu, Peng Lei, Chen Yang, Yifan Zhang, Yuandong Zheng, Xingxing Diao
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Elsevier 2025-05-01
Серии:	Journal of Pharmaceutical Analysis
Предметы:	PROTAC Vepdegestrant (ARV-471) Radiolabeling In vitro–in vivo extrapolation (IVIVE) Physiologically based pharmacokinetic (PBPK) model
Online-ссылка:	http://www.sciencedirect.com/science/article/pii/S2095177924002727
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!